Sign In
Buy SID
$1.31
-0.110 (-7.75%)
At Close: Jun 03, 2026
SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes
03:00am, Monday, 18'th May 2026
SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes PR Newswire
National Steel Q1 Earnings Miss Estimates on Softer Steel Demand
11:40am, Friday, 15'th May 2026
SID incurs a loss in Q1 as softer steel demand, imports and weather drag revenues, though EBITDA rises and margins improve.
National Steel Q1 Earnings Call Highlights
05:13am, Friday, 15'th May 2026
National Steel NYSE: SID, the Brazilian steelmaker known as CSN, reported higher first-quarter 2026 adjusted EBITDA despite heavy rainfall, a stronger Brazilian real and continued pressure from steel
Companhia Siderúrgica Nacional (SID) Q1 2026 Earnings Call Transcript
06:40pm, Thursday, 14'th May 2026
Companhia Siderúrgica Nacional (SID) Q1 2026 Earnings Call Transcript
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence multiple inflammatory pathways. Data supports potential fo
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Ver
LG Display presents future of displays with next-generation OLED technologies at SID Display Week 2026
09:00pm, Monday, 04'th May 2026
SEOUL, South Korea, May 4, 2026 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that it is unveiling its next-generation OLED technologies at SID Dis
CSN announces its Annual Report on Form 20-F for the fiscal year ended December 31, 2025
06:01pm, Thursday, 30'th Apr 2026
SÃO PAULO, April 30, 2026 /PRNewswire/ -- Companhia Siderúrgica Nacional (NYSE: SID and B3: CSNA3) ("CSN") has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with
Two oral presentations including late-breaker at SID Data will cover Phase 1 clinical trial of soquelitinib for atopic dermatitis, including new immunologic and biomarker data supporting drug-free r
Companhia Siderúrgica Nacional (SID) Q4 2025 Earnings Call Transcript
07:22pm, Thursday, 12'th Mar 2026
Companhia Siderúrgica Nacional (SID) Q4 2025 Earnings Call Transcript
Companhia Siderúrgica Nacional (SID) Shareholder/Analyst Call Transcript
04:45pm, Thursday, 15'th Jan 2026
Companhia Siderúrgica Nacional (SID) Shareholder/Analyst Call Transcript
Siderurgica Nacional (SID) Moves to Buy: Rationale Behind the Upgrade
01:01pm, Wednesday, 14'th Jan 2026
Siderurgica Nacional (SID) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Siderurgica Nacional (SID) a Strong Momentum Stock: Buy Now?
01:00pm, Wednesday, 14'th Jan 2026
Does Siderurgica Nacional (SID) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Investors Undervaluing National Steel (SID) Right Now?
10:41am, Wednesday, 14'th Jan 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Siderurgica Nacional (SID) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:56am, Wednesday, 14'th Jan 2026
Siderurgica Nacional (SID) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several st
